|
R3HDM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.612600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.558000E-01 |
| Normal-vs-Stage2 |
4.460800E-01 |
| Normal-vs-Stage3 |
9.090200E-02 |
| Normal-vs-Stage4 |
3.595800E-01 |
| Stage1-vs-Stage2 |
4.189800E-01 |
| Stage1-vs-Stage3 |
5.623800E-02 |
| Stage1-vs-Stage4 |
3.073200E-01 |
| Stage2-vs-Stage3 |
5.812000E-01 |
| Stage2-vs-Stage4 |
9.452600E-01 |
| Stage3-vs-Stage4 |
5.997200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.649200E-01 |
| Normal-vs-AfricanAmerican |
1.032440E-01 |
| Normal-vs-Asian |
1.357430E-01 |
| Caucasian-vs-AfricanAmerican |
1.466580E-01 |
| Caucasian-vs-Asian |
1.860220E-01 |
| AfricanAmerican-vs-Asian |
1.025570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.047000E-01 |
| Normal-vs-Female |
9.200200E-01 |
| Male-vs-Female |
2.126000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.314000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.968400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.983990E-01 |
| Normal-vs-Age(81-100Yrs) |
3.647600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.818000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.763200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.956760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.945410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.052190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.318380E-01 |
| Normal-vs-Grade 2 |
9.212200E-01 |
| Normal-vs-Grade 3 |
1.295180E-01 |
| Normal-vs-Grade 4 |
4.831600E-01 |
| Grade 1-vs-Grade 2 |
2.377800E-01 |
| Grade 1-vs-Grade 3 |
6.302300E-02 |
| Grade 1-vs-Grade 4 |
1.755210E-01 |
| Grade 2-vs-Grade 3 |
1.170420E-01 |
| Grade 2-vs-Grade 4 |
4.911400E-01 |
| Grade 3-vs-Grade 4 |
6.890600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.428800E-01 |
| Normal-vs-ccB subtype |
6.573800E-01 |
| ccA subtype-vs-ccB subtype |
5.724000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.646800E-01 |
| Normal-vs-N1 |
3.826600E-01 |
| N0-vs-N1 |
1.472980E-01 |
|
|
